Find an expert

Prof David Ascher is an NHMRC Investigator Leadership Fellow and Deputy Associate Dean (Research Partnerships) in the Faculty of Science at The University of Queensland. He also serves as Deputy Director of the Australian Centre for Ecogenomics and Head of Computational Biology & Clinical Informatics at the Baker Heart and Diabetes Institute. Internationally, he sits on scientific advisory boards for A*STAR (Singapore), Fiocruz (Brazil) and the Tuscany University Network (Italy), and has been recognised with major honours including the Royal Society of Chemistry Horizon Prize.

A global leader in computational biology and personalised medicine, Prof Ascher develops advanced AI- and structure-based approaches to understand how genetic variation alters protein structure, function, and clinical outcomes. His group has built one of the world’s most widely used platforms for interpreting coding variants—over 90 computational tools, accessed more than 9.5 million times per year from 120+ countries. These tools underpin clinical diagnostics, guide drug development pipelines, and support international public-health responses to antimicrobial resistance and emerging infectious diseases.

His research has led to new molecular insights across infectious disease, rare disease, oncology and cardiometabolic health, and has been translated directly into practice—informing WHO policy, enabling early resistance detection in tuberculosis and leprosy, stratifying patients with hereditary cancers, and supporting vaccine design with partners including Pfizer. Many of his methods are embedded in globally used resources such as Ensembl VEP, PDBe, and the EMBL-EBI KnowledgeBase.

Prof Ascher has a longstanding commitment to interdisciplinary leadership and capability-building across UQ. As Director (Strategy) of the Biotechnology Programs and later as Deputy Associate Dean (Research Partnerships), he has driven initiatives to transform UQ’s biotechnology education, grow industry-embedded training, expand international partnerships, and diversify research income. He has led the development of UQ’s biotechnology–industry placement ecosystem, initiated new professional development programs adopted across multiple Faculties and Institutes, and established major collaborations with government, industry and global research organisations.

He has published more than 250 peer-reviewed papers (over half as senior author: FWCI 2.7), secured more than $30M in competitive research funding, and supervised over 60 HDR students who now hold leadership positions in academia, industry and government. His work appears in leading journals including Nature, Nature Genetics, Science, PNAS and Nature Microbiology, and is cited in over 100 policy documents and 40 patents.

Prof Ascher holds degrees in Biotechnology, Biochemistry, Structural Biology and Law. His research career has spanned Adelaide, Melbourne, Cambridge and Brisbane. After his PhD with Professor Michael Parker, he worked with Sir Tom Blundell at the University of Cambridge, where he led programs in structure-guided drug discovery and protein–protein interaction targeting. He established his independent laboratory at Cambridge and then at the University of Melbourne/Bio21 Institute, before moving to the Baker Institute in 2019 and joining UQ in 2021.

Dr Daniel Edge-Garza is a horticulture and crop geneticist at the Queensland Alliance for Agriculture and Food Innovation at the University of Queensland, Australia. His research interests are to develop and translate tools using genome-wide DNA information for breeders and growers to make meaningful decisions. Daniel’s PhD awarded by the University of Queensland in 2024 focused on identifying global G x E patterns to assist with improved germplasm-environment matching for commercial deployment. Before joining QAAFI, he obtained his Bachelor's Degree in Biological Sciences in 2005 and Master's Degree in Biotechnology in 2009 both at California State University, Fresno. From 2008, he worked as a faculty associate in research for tree fruit breeding at Washington State University becoming recognized worldwide for his efforts to streamline the deployment of DNA tests for pome and stone fruit breeding programs. He has also collaborated with the Genome Database for Rosaceae since 2018 to curate genomics data and train breeders on how to upload and access their data on the Breeding Information Management System.

Valentin was awarded a PhD from the French National Institute of Higher Education in Agricultural Sciences and the University of Montpellier (France) in 2018. His thesis focused on methodological developments for genetic differentiation analysis in the Next Generation Sequencing era in a neutral and adaptive context. Since 2019, he works as a post-doctoral researcher at the University of Queensland in the Program in Complex Trait Genomics group under the supervision of Professor Peter Visscher. His current research focuses on studying the within and between-population genetic variation in human complex traits.

In The Ortiz-Barrientos Lab we seek to understand how natural selection drives the origin of traits and new species. We combine empirical and theoretical approaches from across multiple disciplines.

We are located in beautiful Brisbane, Australia, in the School of The Environment at The University of Queensland.

Please explore our pages to learn about research, culture, and the team of scientists that bring their passion and creativity to discovering how nature works.

Dr Jian Zeng is a statistical geneticist and NHMRC Emerging Leadership Fellow at the Institute for Molecular Bioscience (IMB) at the University of Queensland (UQ). He received his PhD in animal breeding and genetics at Iowa State University and joined the Program in Complex Trait Genomics (PCTG) at UQ in 2016. His research focuses on the development and application of innovative statistical methods for estimating the genetic architecture and evolutionary signals in complex traits, identifying genetic variants, genes and other molecular intermediates associated with phenotype variation, and predicting trait phenotypes using genome sequence data. In 2019, he was awarded an NHMRC Investigator Emerging Leadership Grant to develop statistical methods and software tools for best predict an individual’s disease risk using genomic and omics data. He was an invited speaker at the prestigious Gordon Research Conference in 2019.